SI-BONE, Inc. (SIBN) stock
SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3042% above fair value
$23.16−0.25 (-1.07%)
Close on Nov 17, 2026Market cap $1.04BP/E –Yield 0.00%
Si-Bone ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Si-Bone's ebitda for the twelve months ending Jun 30, 2026 was -$11.33M. For fiscal 2025 it was -$16.56M. The highest annual figure on record is -$11.24M in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$16.56M | – |
| FY2024 | Dec 31, 2024 | -$30.87M | – |
| FY2023 | Dec 31, 2023 | -$41.50M | – |
| FY2022 | Dec 31, 2022 | -$56.16M | – |
| FY2021 | Dec 31, 2021 | -$49.58M | – |
| FY2020 | Dec 31, 2020 | -$37.44M | – |
| FY2019 | Dec 31, 2019 | -$35.23M | – |
| FY2018 | Dec 31, 2018 | -$11.24M | – |
| FY2017 | Dec 31, 2017 | -$16.34M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.13M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.48M | – |
| Q4 FY2025 | Dec 31, 2025 | -$825.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.90M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.64M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.20M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.28M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.55M | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.09M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.95M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.93M | – |
| Q3 FY2023 | Sep 30, 2023 | -$9.64M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.73M | – |
| Q1 FY2023 | Mar 31, 2023 | -$10.21M | – |
| Q4 FY2022 | Dec 31, 2022 | -$10.29M | – |
| Q3 FY2022 | Sep 30, 2022 | -$12.62M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.09M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.16M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.28M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.61M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.46M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.24M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.53M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.39M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.88M | – |
| Q1 FY2020 | Mar 31, 2020 | -$11.63M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.28M | – |
| Q3 FY2019 | Sep 30, 2019 | -$10.41M | – |
| Q2 FY2019 | Jun 30, 2019 | -$7.94M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.61M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.12M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.86M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.51M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.75M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.45M | – |
See a number that looks wrong?